JPRN-UMIN000006634Completed未知
Pharmacokinetics and pharmacogenomics study with erlotinib in the treatment of advanced non-small cell lung cancer (NSCLC) - PK/PG study with erlotinib in NSCLC
Department of Respiratory Medicine / Keio Cancer Center, School of Medicine, Keio University0 sites40 target enrollmentStarted: November 1, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Without concent
Investigators
Similar Trials
Completed
Not Applicable
Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxifeBreast cancerJPRN-UMIN000001411Saitama Medical University, Saitama International Medical Center100
Completed
Not Applicable
Research of pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of 5-Fluorouracil in colorectal cancer patientsColorectal cancerJPRN-UMIN000004095Department of clinical pharmacokinetics, Graduate school of Pharmaceutical Science, Kyushu University30
Recruiting
Not Applicable
An exploratory pharmacokinetic and pharmacodynamic study of beta-lactam and fluoroquinolone in ICU patients10004018bacterial infectionSepsisNL-OMON43959Erasmus MC, Universitair Medisch Centrum Rotterdam200
Not yet recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
Recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperidememory impairmentNL-OMON47428niversiteit Maastricht42